Using cell-specific late-phase asthma mRNA biomarkers to repurpose drugs that concurrently reverse disease signatures across multiple immune cell-types.
Saved in:
| Title: | Using cell-specific late-phase asthma mRNA biomarkers to repurpose drugs that concurrently reverse disease signatures across multiple immune cell-types. |
|---|---|
| Authors: | Zhang M; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada.; UBC Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, British Columbia, Canada.; Providence Research, Providence Health Care, Vancouver, British Columbia, Canada., Kim YW; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada.; UBC Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, British Columbia, Canada.; Providence Research, Providence Health Care, Vancouver, British Columbia, Canada., Yang CX; UBC Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, British Columbia, Canada., Gauvreau GM; Department of Medicine, McMaster University, Hamilton, Ontario, Canada., FitzGerald JM; Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Boulet LP; Centre de Pneumologie de L'Hopital, Université Laval, Québec City, Québec, Canada., O'Byrne PM; Department of Medicine, McMaster University, Hamilton, Ontario, Canada., Tebbutt SJ; UBC Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, British Columbia, Canada.; Providence Research, Providence Health Care, Vancouver, British Columbia, Canada.; Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; PROOF Centre of Excellence, Vancouver, British Columbia, Canada., Singh A; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada.; UBC Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, British Columbia, Canada.; Providence Research, Providence Health Care, Vancouver, British Columbia, Canada. |
| Source: | PLoS computational biology [PLoS Comput Biol] 2026 Apr 03; Vol. 22 (4), pp. e1014081. Date of Electronic Publication: 2026 Apr 03 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238922 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7358 (Electronic) Linking ISSN: 1553734X NLM ISO Abbreviation: PLoS Comput Biol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41931526 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Using cell-specific late-phase asthma mRNA biomarkers to repurpose drugs that concurrently reverse disease signatures across multiple immune cell-types. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Zhang+M%22">Zhang M</searchLink>; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada.; UBC Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, British Columbia, Canada.; Providence Research, Providence Health Care, Vancouver, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Kim+YW%22">Kim YW</searchLink>; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada.; UBC Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, British Columbia, Canada.; Providence Research, Providence Health Care, Vancouver, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Yang+CX%22">Yang CX</searchLink>; UBC Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Gauvreau+GM%22">Gauvreau GM</searchLink>; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22FitzGerald+JM%22">FitzGerald JM</searchLink>; Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Boulet+LP%22">Boulet LP</searchLink>; Centre de Pneumologie de L'Hopital, Université Laval, Québec City, Québec, Canada.<br /><searchLink fieldCode="AU" term="%22O'Byrne+PM%22">O'Byrne PM</searchLink>; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Tebbutt+SJ%22">Tebbutt SJ</searchLink>; UBC Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, British Columbia, Canada.; Providence Research, Providence Health Care, Vancouver, British Columbia, Canada.; Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; PROOF Centre of Excellence, Vancouver, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Singh+A%22">Singh A</searchLink>; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada.; UBC Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, British Columbia, Canada.; Providence Research, Providence Health Care, Vancouver, British Columbia, Canada. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101238922%22">PLoS computational biology</searchLink> [PLoS Comput Biol] 2026 Apr 03; Vol. 22 (4), pp. e1014081. <i>Date of Electronic Publication: </i>2026 Apr 03 (<i>Print Publication: </i>2026). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101238922 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1553-7358 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221553734X%22">1553734X </searchLink><i>NLM ISO Abbreviation: </i>PLoS Comput Biol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41931526 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1371/journal.pcbi.1014081 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e1014081 Titles: – TitleFull: Using cell-specific late-phase asthma mRNA biomarkers to repurpose drugs that concurrently reverse disease signatures across multiple immune cell-types. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Zhang M – PersonEntity: Name: NameFull: Kim YW – PersonEntity: Name: NameFull: Yang CX – PersonEntity: Name: NameFull: Gauvreau GM – PersonEntity: Name: NameFull: FitzGerald JM – PersonEntity: Name: NameFull: Boulet LP – PersonEntity: Name: NameFull: O'Byrne PM – PersonEntity: Name: NameFull: Tebbutt SJ – PersonEntity: Name: NameFull: Singh A IsPartOfRelationships: – BibEntity: Dates: – D: 03 M: 04 Text: 2026 Apr 03 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1553-7358 Numbering: – Type: volume Value: 22 – Type: issue Value: 4 Titles: – TitleFull: PLoS computational biology Type: main |
| ResultId | 1 |